EHA endorsement of ESMO clinical practice guidelines for newly diagnosed and relapsed mantle cell lymphoma
Affiliation
Division of Cancer Sciences, School of Medicine Sciences, University of Manchester, Manchester Cancer Research Centre, Manchester, UK.Issue Date
2020
Metadata
Show full item recordCitation
Linton K, Dreyling M. EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma. Hemasphere. 2020;4(5):e464.Journal
HemasphereDOI
10.1097/hs9.0000000000000464PubMed ID
32885149Additional Links
https://dx.doi.org/10.1097/hs9.0000000000000464Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1097/hs9.0000000000000464
Scopus Count
Collections
Related articles
- EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma.
- Authors: Ladetto M, Dreyling M
- Issue date: 2021 May
- Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
- Authors: Dreyling M, Geisler C, Hermine O, Kluin-Nelemans HC, Le Gouill S, Rule S, Shpilberg O, Walewski J, Ladetto M, ESMO Guidelines Working Group
- Issue date: 2014 Sep
- EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas.
- Authors: Ladetto M, Dreyling M
- Issue date: 2020 Apr
- EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes.
- Authors: van de Loosdrecht AA, Mandac Smoljanović I
- Issue date: 2022 Mar
- EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia.
- Authors: Eichhorst B, Ghia P
- Issue date: 2021 Jan